760039

    544619

    SUDEEPPHRM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Sudeep Pharma Limited Share Price Today

    SUDEEP PHARMA LIMITED is currently trading at ₹847.55, up by ₹23.29 from the previous close. During the latest trading session, the stock touched an intraday high of ₹862.20 and a low of ₹811.00. Over the past six months, SUDEEP PHARMA LIMITED has delivered a return of 6.47%, while the stock has gained 12.69% in the last one month.

    Sudeep Pharma Limited performance

    Today’s low Today’s high
    ₹ 811.00 ₹ 862.20
    ₹ 847.55
    52 week low 52 week high
    ₹ 524.05 ₹ 894.45
    ₹ 847.55
    Open Price ₹ 811.00
    Prev. Close ₹ 824.25
    Volume (Shares) 233753.00
    Total traded value ₹ 1981.17
    Upper Circuit ₹ 906.65
    Lower Circuit ₹ 741.85
    info

    Investment Returns

    Over 1 Month 12.69% Over 3 Months 35.15% Over 6 Months 37.05% Over 1 Year 6.47%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Sudeep Pharma Limited fundamentals


    • Market cap (Cr) 9,573.00
    • P/E Ratio (TTM) 86.49
    • Beta 0.91
    • Book Value / share 69.58
    • Return on equity 25.12%
    • EPS (TTM) 9.52
    • Dividend yield 0.18%
    • Net profit/quarter (Cr) 25.77
    info icon alternate text
    • Market cap (Cr) 9,547.50
    • P/E Ratio (TTM) 86.49
    • Beta 0.74
    • Book Value / share 69.58
    • Return on equity 25.12%
    • EPS (TTM) 9.52
    • Dividend yield 0.18%
    • Net profit/quarter (Cr) 25.77
    info icon alternate text

    Sudeep Pharma Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 80.17
    Operating Expense 55.04
    Net Profit 25.77
    Net Profit Margin (%) 32.14
    Earnings Per Share (EPS) 2.31
    EBITDA 38.50
    Effective Tax Rate (%) 25.84
    Particulars DEC 2025 (Values in Cr)
    Revenue 90.28
    Operating Expense 63.09
    Net Profit 26.87
    Net Profit Margin (%) 29.76
    Earnings Per Share (EPS) 2.42
    EBITDA 39.04
    Effective Tax Rate (%) 26.65
    Particulars SEP 2025 (Values in Cr)
    Revenue 87.88
    Operating Expense 60.81
    Net Profit 29.74
    Net Profit Margin (%) 33.84
    Earnings Per Share (EPS) 2.67
    EBITDA 43.70
    Effective Tax Rate (%) 25.46
    Particulars JUN 2025 (Values in Cr)
    Revenue 80.17
    Operating Expense 52.97
    Net Profit 25.20
    Net Profit Margin (%) 31.43
    Earnings Per Share (EPS) 2.29
    EBITDA 37.01
    Effective Tax Rate (%) 25.48
    Particulars MAR 2025 (Values in Cr)
    Revenue 104.85
    Operating Expense 62.67
    Net Profit 33.14
    Net Profit Margin (%) 31.60
    Earnings Per Share (EPS) 3.05
    EBITDA 48.57
    Effective Tax Rate (%) 26.83
    Particulars MAR 2026 (Values in Cr)
    Revenue 338.51
    Operating Expense 231.92
    Net Profit 107.58
    Net Profit Margin (%) 31.78
    Earnings Per Share (EPS) 9.65
    EBITDA 158.28
    Effective Tax Rate (%) 25.85
    Particulars MAR 2025 (Values in Cr)
    Revenue 356.73
    Operating Expense 235.70
    Net Profit 95.75
    Net Profit Margin (%) 26.84
    Earnings Per Share (EPS) 8.82
    EBITDA 140.34
    Effective Tax Rate (%) 26.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 50.48
    ROE % 32.75
    ROCE % 35.54
    Total Debt to Total Equity 0.25
    EBITDA Margin 39.91
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 252.69
    ROE % 45.98
    ROCE % 48.39
    Total Debt to Total Equity 0.28
    EBITDA Margin 41.06
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 158.47
    ROE % 32.24
    ROCE % 33.09
    Total Debt to Total Equity 0.43
    EBITDA Margin 23.25
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 1159.15
    ROE % 36.15
    ROCE % 35.69
    Total Debt to Total Equity 0.41
    EBITDA Margin 21.82
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 810.48
    ROE % 34.17
    ROCE % 35.43
    Total Debt to Total Equity 0.26
    EBITDA Margin 22.09
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 44.01
    ROE % 25.12
    ROCE % 28.51
    Total Debt to Total Equity 0.24
    EBITDA Margin 39.58
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 2374.56
    ROE % 34.32
    ROCE % 38.66
    Total Debt to Total Equity 0.23
    EBITDA Margin 41.06
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1681.07
    ROE % 33.16
    ROCE % 34.81
    Total Debt to Total Equity 0.35
    EBITDA Margin 24.86
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 1193.96
    ROE % 36.81
    ROCE % 36.98
    Total Debt to Total Equity 0.36
    EBITDA Margin 22.10
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 822.76
    ROE % 35.54
    ROCE % 36.73
    Total Debt to Total Equity 0.26
    EBITDA Margin 22.70
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 51.80
    Total Assets 717.17
    Total Liabilities 717.17
    Total Equity 493.09
    Share Outstanding 9
    Price to Book Ratio 0.00
    Return on Assets (%) 19.33
    Return on Capital (%) 22.07
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.97
    Total Assets 513.86
    Total Liabilities 513.86
    Total Equity 356.03
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 25.91
    Return on Capital (%) 30.9
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 10.30
    Total Assets 420.11
    Total Liabilities 420.11
    Total Equity 223.28
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 14.83
    Return on Capital (%) 20.4
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 21.47
    Total Assets 343.80
    Total Liabilities 343.80
    Total Equity 163.33
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 14.59
    Return on Capital (%) 20.31
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 11.95
    Total Assets 212.70
    Total Liabilities 212.70
    Total Equity 114.20
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 15.67
    Return on Capital (%) 22.95
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 45.34
    Total Assets 604.09
    Total Liabilities 604.09
    Total Equity 430.11
    Share Outstanding 9
    Price to Book Ratio 0.00
    Return on Assets (%) 15.84
    Return on Capital (%) 17.45
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.59
    Total Assets 450.59
    Total Liabilities 450.59
    Total Equity 334.59
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 21.76
    Return on Capital (%) 24.98
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 6.35
    Total Assets 416.02
    Total Liabilities 416.02
    Total Equity 236.87
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 16.14
    Return on Capital (%) 21.91
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 14.87
    Total Assets 333.16
    Total Liabilities 333.16
    Total Equity 168.24
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 15.69
    Return on Capital (%) 21.71
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 8.19
    Total Assets 213.81
    Total Liabilities 213.81
    Total Equity 115.93
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 16.36
    Return on Capital (%) 23.8
    Particulars MAR 2025 (Values in Cr)
    Net Income 182.84
    Cash from Operations 89.27
    Cash from Investing -78.75
    Cash from Financing 52.69
    Net change in Cash 22.66
    Free Cash Flow 153.51
    Particulars MAR 2024 (Values in Cr)
    Net Income 174.81
    Cash from Operations 110.43
    Cash from Investing -49.28
    Cash from Financing -12.73
    Net change in Cash 3.66
    Free Cash Flow 162.89
    Particulars MAR 2023 (Values in Cr)
    Net Income 85.98
    Cash from Operations 70.81
    Cash from Investing -50.01
    Cash from Financing -9.77
    Net change in Cash -11.39
    Free Cash Flow 117.96
    Particulars MAR 2022 (Values in Cr)
    Net Income 68.60
    Cash from Operations 14.59
    Cash from Investing -38.41
    Cash from Financing 50.91
    Net change in Cash 9.51
    Free Cash Flow 88.21
    Particulars MAR 2021 (Values in Cr)
    Net Income 43.02
    Cash from Operations 45.87
    Cash from Investing -40.41
    Cash from Financing 12.99
    Net change in Cash 7.85
    Free Cash Flow 57.56
    Particulars MAR 2025 (Values in Cr)
    Net Income 129.40
    Cash from Operations 88.82
    Cash from Investing -91.59
    Cash from Financing 54.19
    Net change in Cash 21.75
    Free Cash Flow 149.90
    Particulars MAR 2024 (Values in Cr)
    Net Income 132.30
    Cash from Operations 95.27
    Cash from Investing -40.66
    Cash from Financing -16.14
    Net change in Cash 2.24
    Free Cash Flow 127.09
    Particulars MAR 2023 (Values in Cr)
    Net Income 90.77
    Cash from Operations 64.09
    Cash from Investing -40.71
    Cash from Financing -10.11
    Net change in Cash -8.52
    Free Cash Flow 102.45
    Particulars MAR 2022 (Values in Cr)
    Net Income 70.40
    Cash from Operations 11.73
    Cash from Investing -27.96
    Cash from Financing 39.97
    Net change in Cash 6.67
    Free Cash Flow 68.66
    Particulars MAR 2021 (Values in Cr)
    Net Income 44.95
    Cash from Operations 46.39
    Cash from Investing -44.71
    Cash from Financing 12.99
    Net change in Cash 4.09
    Free Cash Flow 58.08
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD. 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD. 521.10 56.34 4.78 5526.59 118.35 552.90

    Sudeep Pharma Limited shareholding pattern

    Holding
    4.18%
    76.15%
    1.55%
    18.11%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Sudeep Pharma Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    847.55 2.82 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 818.00
    • 26 Days 802.70
    • 10 Days 822.20
    • 50 Days 764.20
    • 12 Days 821.80
    • 100 Days 716.80
    • 20 Days 812.70
    • 200 Days 668.30
    821.97 PIVOT
    First Support 809.43 First Resistance 836.78 Second Support 794.62 Second Resistance 849.32 Third Support 782.08 Third Resistance 864.13
    RSI 55.24 ADX 31.01 MACD 19.09 Williams % R -66.16 Commodity Channel Index (CCI) -30.73
    Date 2026-07-10 Week 111002.00 Same Day 91938.00 Month 159541.00
    1 Year 0.92 3 Year 0.92
    Over 1 Month
    12.69% down
    Over 1 Year
    6.47% down
    Over 3 Months
    35.15% down
    Over 3 Years
    0.00% down
    Over 6 Months
    37.05% down
    Over 5 Years
    0.00% down

    Sudeep Pharma Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jul 2026 1.5 Final 23 Jul 2026 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jul 2026 1.5 Final 23 Jul 2026 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Sudeep Pharma Ltd?

    Answer Field

    Sudeep Pharma Ltd share price is for NSE ₹ 847.55 & for BSE ₹ 845.30 as on Jul 13 2026 03:30 PM.

    What is the Market Cap of Sudeep Pharma Ltd Share?

    Answer Field

    The market cap of Sudeep Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 13 2026 03:30 PM.

    What is the 52 Week High and Low of Sudeep Pharma Ltd?

    Answer Field

    The 52 Week High and Low of Sudeep Pharma Ltd for NSE is ₹ 894.45 and ₹ 524.05 and for BSE is ₹ 893.40 and ₹ 524.95.

    What is 1 year return for Sudeep Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been 6.47%.

    What is the P/E Ratio of Sudeep Pharma Ltd Share?

    Answer Field

    As on Jul 13 2026 03:30 PM the price-to-earnings (PE) ratio for Sudeep Pharma Ltd share is 86.49.

    What is the PB ratio of Sudeep Pharma Ltd Share?

    Answer Field

    As on Jul 13 2026 03:30 PM, the price-to-book (PB) ratio for Sudeep Pharma Ltd share is 69.58.

    How to Buy Sudeep Pharma Ltd Share?

    Answer Field

    You can trade in Sudeep Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Sudeep Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Sudeep Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Sudeep Pharma Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |